Celularity (CELU) Other Non Operating Income (2020 - 2025)
Celularity (CELU) posted quarterly Other Non Operating Income of $6.6 million for Q4 2025, up 10574.19% quarter-over-quarter from $62000.0 in Q3 2025.
Celularity (CELU) Other Non Operating Income (2020 - 2025) Analysis & Trends
Celularity (CELU) has reported Other Non Operating Income for 6 consecutive years, with $6.6 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Other Non Operating Income changed N/A year-over-year to $6.6 million; the TTM figure through Dec 2025 stood at $1.0 million (up 296.06% YoY), while the FY2025 annual figure was $262000.0, up 106.7% from the prior year.
- Other Non Operating Income grew to $6.6 million in Q4 2025 per CELU's latest filing, from $62000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $117.8 million in Q4 2023 and bottomed at -$5.7 million in Q1 2025.
- Historically, Other Non Operating Income has averaged $6.7 million across 5 years, with a median of $72000.0 in 2024.
- Annual changes were most pronounced in 2023 — Other Non Operating Income soared 55993.33% — and 2025, when it slumped 5314.55%.
- Celularity's Other Non Operating Income stood at $8000.0 in 2021, then jumped by 2525.0% to $210000.0 in 2022, then jumped by 55993.33% to $117.8 million in 2023, then sank by 99.93% to $77000.0 in 2024, then jumped by 8494.81% to $6.6 million in 2025.
- Business Quant data shows CELU's Other Non Operating Income at $6.6 million in Q4 2025, $62000.0 in Q3 2025, and $62000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Celularity | 20.99 Mn | 14.82 Mn | -3.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.62 Mn |
| Sep 30, 2025 | 62,000.00 |
| Jun 30, 2025 | 62,000.00 |
| Mar 31, 2025 | -5.74 Mn |
| Sep 30, 2024 | 77,000.00 |
| Jun 30, 2024 | 67,000.00 |
| Mar 31, 2024 | 110,000.00 |
| Dec 31, 2023 | 117.80 Mn |
| Jun 30, 2023 | 66,000.00 |
| Mar 31, 2023 | 116,000.00 |
| Dec 31, 2022 | 210,000.00 |
| Sep 30, 2022 | 108,000.00 |
| Jun 30, 2022 | 41,000.00 |
| Mar 31, 2022 | 6,000.00 |
| Dec 31, 2021 | 8,000.00 |
| Sep 30, 2021 | 55,000.00 |
| Jun 30, 2021 | 129,000.00 |
| Mar 31, 2021 | 140,000.00 |
| Dec 31, 2020 | 134,000.00 |
| Sep 30, 2020 | 92,000.00 |